Fig. 7: Schematic graph for proposed MOA of 9MW3811’s anti-tumor activity.

By neutralizing IL-11, 9MW3811 can inhibit tumor cell proliferation, promote the terminal differentiation of proinflammatory macrophages, increase T cell infiltration, and enhance T cell cytotoxicity against tumor cells.